Ferroptotic Cell Death in Adrenal Inflammation and Septic Shock

Rapid release of adrenal stress hormones is essential for survival during sepsis, a life-threatening syndrome characterized by dysregulated host responses to infection and subsequent multiorgan dysfunction. Owing to their dense vascularization and the generation of reactive oxygen species during steroidogenesis, adrenal glands are particularly susceptible to sepsis-induced injury. Indeed, severe infections are frequently associated with adrenal hemorrhage, inflammation, infarction, and necrosis, which may contribute to adrenal insufficiency and poor clinical outcomes.

Recent evidence, including our own findings, suggests that regulated necrosis plays an important role in sepsis-induced organ damage. However, the mechanisms underlying adrenal cell death during sepsis remain incompletely understood. Our preliminary studies identified ferroptosis, an iron-dependent form of regulated necrosis driven by lipid peroxidation, as a major cell death pathway in adrenocortical cells. Pharmacological inhibition of glutathione peroxidase 4 (GPX4) in the human adrenocortical cell line NCI-H295R resulted in increased lipid peroxidation and necrotic cell death, which could be prevented by ferroptosis inhibitors. Preliminary data further suggest that similar mechanisms may operate in non-transformed adrenal tissue.

The aim of this project is to investigate the contribution of ferroptosis to sepsis-induced adrenal gland damage and dysfunction. Using established in vitro and ex vivo models including adrenal cell lines and primary mouse adrenal spheroids, the project will assess ferroptosis induction, characterize its molecular regulation, and evaluate the protective potential of ferroptosis-targeting interventions. Particular emphasis will be placed on the roles of GPX4, lipid peroxidation, and iron metabolism in maintaining adrenocortical cell viability under inflammatory conditions.

References: 

  1. Tonnus W, Maremonti F, Gavali S, Schlecht MN, Belavgeni A, et al. Multiple oestradiol functions inhibit ferroptosis and acute kidney injury. Nature. 2025;645:1011–1019.

  2. Van Coillie S, Van San E, Goetschalckx I, Wiernicki B, Mukhopadhyay B, Tonnus W, et al. Targeting ferroptosis protects against experimental (multi)organ dysfunction and death. Nat Commun. 2022;13:1046.

  3. Kanczkowski W, Evert K, Stadtmüller M, Haberecker M, Laks L, Chen LS, et al. COVID-19 targets human adrenal glands. Lancet Diabetes Endocrinol. 2022;10(6):437–446.

  4. Tonnus W, Linkermann A. The role of regulated necrosis in endocrine diseases. Nat Rev Endocrinol. 2021;17(8):497–510.

  5. Belavgeni A, Meyer C, Stumpf J, Hugo C, Linkermann A, et al. Exquisite sensitivity of adrenocortical carcinomas to induction of ferroptosis. Proc Natl Acad Sci U S A. 2019;116(44):22269–22274.

Art der Promotion
experimentell
Forschungssemester notwendig?
ja, zwei Semester
Finanzierung/Anstellung
Nein
Angeschlossen an ein strukturiertes Promotionsprogramm?
Ja Ferroptotic Cell Death in Adrenal Inflammation and Septic Shock (CRC-TRR 205/A01)
Zeitplan
01.09.26 12 Monate
Abteilung / Struktureinheit
MK3 | Medizinische Klinik und Poliklinik III
ein Dokument mit weiterführenden Informationen
Keine Datei

Betreuung

Erstbetreuung
weitere Betreuende

Relevante/Repräsentative Publikation mit evtl. Vordaten

Methodik/Aufgaben

Experimentell
Molekularbiologische Methoden, Tiermodell, Imaging, Zellkultur, Histologie
klinisch
Patient:innenproben
theoretisch
statistisch
Digitale Datenauswertung

Bewerbung

E-Mail
Bewerber:innen-Profil
Wir suchen nach einer/m Medizinstudent:in für dieses Projekt im Rahmen des CRC-TRR 205
Benötigte Bewerbungsunterlagen
Motivationsschreiben, Zeugnis des letzten Staatsexamens, Lebenslauf